News Stories

In order to bring further insight and understanding surrounding PCSK9 antibodies and their use in clinical practice, the NLA will host an in-depth supplemental symposium to be held in conjunction with the NLA 2016 Fall Clinical Lipid Update. This 2-hour symposium, held Friday, August 26 from 6:45–9:00 p.m., will present the latest data and usage guidelines surrounding this new class of lipid-lowering therapies.

The new ICD-10 Codes were released by the Center for Medicare & Medicaid Services (CMS). Two new specific codes for FH have been approved:

• E78.01: Familial hypercholesterolemia
• Z83.42: Family history of familial hypercholesterolemia

The National Lipid Association (NLA) in collaboration with the FH Foundation submitted a proposal to the ICD-10 Coordination and Maintenance Committee to create new, specific ICD-10 codes for FH in January 2014.

The 2015 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw yet another significant increase — from 3.904 (2014) to 4.906 (2015). The Journal is now ranked 23rd out of 253 journals in its category (pharmacology and pharmacy). The Thomson-Reuters Impact Factor represents the ratio of articles quoted in other scientific publications